Deborah McCue

1.3k total citations
14 papers, 582 citations indexed

About

Deborah McCue is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Deborah McCue has authored 14 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Deborah McCue's work include Acute Myeloid Leukemia Research (6 papers), Histone Deacetylase Inhibitors Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Deborah McCue is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Histone Deacetylase Inhibitors Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Deborah McCue collaborates with scholars based in United States. Deborah McCue's co-authors include Hagop M. Kantarjian, Farhad Ravandi, Jörge E. Cortes, Lisa Lohr, Amy M. Pick, Guillermo Garcia‐Manero, Elias Jabbour, Gautam Borthakur, Stefan Faderl and Naveen Pemmaraju and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Deborah McCue

14 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah McCue United States	9	320	194	175	123	80	14	582
Lisa Madden United States	9	232 0.7×	62 0.3×	98 0.6×	87 0.7×	67 0.8×	17	506
Youcef Chelghoum France	12	269 0.8×	180 0.9×	134 0.8×	151 1.2×	85 1.1×	35	466
Jassada Buaboonnam Thailand	11	273 0.9×	166 0.9×	167 1.0×	146 1.2×	111 1.4×	28	571
Kayleigh Marx United States	10	368 1.1×	116 0.6×	195 1.1×	122 1.0×	117 1.5×	21	620
Michael C. Stephens United States	14	91 0.3×	94 0.5×	51 0.3×	46 0.4×	9 0.1×	37	673
Arancha Bermúdez Spain	9	212 0.7×	59 0.3×	95 0.5×	162 1.3×	48 0.6×	25	371
Xiaowen Zhai China	12	115 0.4×	113 0.6×	120 0.7×	99 0.8×	50 0.6×	66	406
Afiba Manza‐A. Agovi United States	10	384 1.2×	134 0.7×	38 0.2×	100 0.8×	74 0.9×	18	481
Brigitte Witz France	8	203 0.6×	116 0.6×	101 0.6×	257 2.1×	45 0.6×	17	399
Maria Aparecida Zanichelli Brazil	12	226 0.7×	63 0.3×	105 0.6×	194 1.6×	179 2.2×	28	469

Countries citing papers authored by Deborah McCue

Since Specialization

Citations

This map shows the geographic impact of Deborah McCue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah McCue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah McCue more than expected).

Fields of papers citing papers by Deborah McCue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah McCue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah McCue. The network helps show where Deborah McCue may publish in the future.

Co-authorship network of co-authors of Deborah McCue

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah McCue. A scholar is included among the top collaborators of Deborah McCue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah McCue. Deborah McCue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Sasaki, Koji, Caitlin R. Rausch, Courtney D. DiNardo, et al.. (2023). Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients. Leukemia & lymphoma. 65(3). 378–382. 6 indexed citations

McCue, Deborah, et al.. (2020). Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm. Expert Review of Anticancer Therapy. 20(7). 543–550. 7 indexed citations

Economides, Minas P., Deborah McCue, Andrew A. Lane, & Naveen Pemmaraju. (2019). Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm. Expert Review of Clinical Pharmacology. 12(10). 941–946. 17 indexed citations

Economides, Minas P., Deborah McCue, Gautam Borthakur, & Naveen Pemmaraju. (2019). Topoisomerase II inhibitors in AML: past, present, and future. Expert Opinion on Pharmacotherapy. 20(13). 1637–1644. 33 indexed citations

Paul, Shilpa, et al.. (2017). Pneumocystis Jiroveci Pneunomia Prophylaxis during Maintenance Therapy with Hyper-CVAD Regimens for Adult Acute Lymphoblastic Leukemia. Blood. 130. 1295–1295. 1 indexed citations

Wang, Emily, Dimitrios Farmakiotis, Deborah McCue, et al.. (2015). The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. Journal of Antimicrobial Chemotherapy. 70(8). 2362–2368. 68 indexed citations

Ravandi, Farhad, Susan O’Brien, Jörge E. Cortes, et al.. (2015). Long‐term follow‐up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome–positive acute lymphoblastic leukemia. Cancer. 121(23). 4158–4164. 156 indexed citations

McCue, Deborah, Lisa Lohr, & Amy M. Pick. (2014). Improving Adherence to Oral Cancer Therapy in Clinical Practice. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 34(5). 481–494. 64 indexed citations

McCue, Deborah, et al.. (2013). Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia. Journal of Oncology Pharmacy Practice. 20(6). 403–408. 9 indexed citations

10.

Garcia‐Manero, Guillermo, Francesco Paolo Tambaro, N. Bekele, et al.. (2012). Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome. Journal of Clinical Oncology. 30(18). 2204–2210. 124 indexed citations

11.

Sharma, Manish, Farhad Ravandi, Ulas D. Bayraktar, et al.. (2011). Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with Sorafenib. Biology of Blood and Marrow Transplantation. 17(12). 1874–1877. 73 indexed citations

12.

Garcia‐Manero, Guillermo, Francesco Paolo Tambaro, N. Bekele, et al.. (2011). Final Report of a Phase II Trial of Vorinostat with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS). Blood. 118(21). 763–763. 1 indexed citations

13.

Kantarjian, Hagop M., Jean‐Pierre J. Issa, Elias Jabbour, et al.. (2010). Feasibility of Therapy With Hypomethylating Agents in Patients With Renal Insufficiency. Clinical Lymphoma Myeloma & Leukemia. 10(3). 205–210. 21 indexed citations

14.

Mattiuzzi, Gloria, Jörge E. Cortes, Deborah McCue, et al.. (2009). Palonosetron (PALO) Given Daily for up to 5 Days Is Significantly Better Than Ondansetron (ONDA) in the Prevention of Delayed CINV in Patients (pts) with Acute Myelogenous Leukemia (AML).. Blood. 114(22). 993–993. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact